Captopril/Hydrochlorothiazide

卡托普利/氢氯噻嗪

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCaptopril/Hydrochlorothiazide
Drug Alias Name氢氯噻嗪-卡托普利Hydrochlorothiazide•Captopril氢氯噻嗪和卡托普利Hydrochlorothiazide and Captopril卡托普利氢氯噻嗪 +[10] 
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsAngiotensin-converting enzyme inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1984/10/12
Country/TerritoryUnited StatesMainland China
CombinationsYes HydrochlorothiazideCaptopril
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesChangzhou Pharmaceutical Factory
Inactive CompaniesGlaxosmithkline PlcApothecon Llc
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BA01
Related LinksKEGG